What is the main reason for this 8-K filing?

The primary reason for this 8-K filing is to confirm that Anthem, Inc. (now Elevance Health) expects to meet its previously announced earnings expectations, notwithstanding a recent adverse legal opinion from the Supreme Court of Ohio.

What is the legal matter mentioned in the filing, and why is it relevant?

The legal matter is the case of Robert Lee Dardinger, Executor of the Estate of Esther Louise Dardinger v. Anthem Blue Cross and Blue Shield, et al., where the Supreme Court of Ohio issued an opinion on December 20, 2002. It's relevant because the company is proactively addressing investor concerns by stating that this opinion is not expected to prevent them from meeting their financial guidance.

When can investors expect to hear more from the company's management?

Company officers are scheduled to meet with securities analysts and investors during the weeks of December 23, 2002, December 30, 2002, and January 6, 2003, to discuss the company's performance and outlook.

What are the key risks the company highlights for its future performance?

The company highlights several risks, including fluctuations in healthcare costs and utilization, the ability to secure adequate premium rate increases, competitive pricing, increased government regulation, significant competitor actions, advancements in medical technology and drugs, potential downgrades in financial strength ratings, litigation, integration of acquisitions like Trigon Healthcare, Inc., and general economic downturns.

ELV 8-K SEC Disclosure — Dec 23, 2002

Summary

Elevance Health, Inc. (ELV), formerly Anthem, Inc., filed an 8-K on December 23, 2002, to disclose information relevant to upcoming meetings with securities analysts and investors. The primary purpose of this filing was to confirm the company's ability to meet previously issued earnings expectations for the period, despite a recent adverse opinion from the Supreme Court of the State of Ohio concerning a legal matter. This confirmation aims to reassure investors and analysts that the legal development, while noted, is not expected to derail the company's financial performance targets. The filing also reiterates the forward-looking nature of the company's statements and the inherent risks and uncertainties associated with its business. Investors are advised to review these risks, which include factors such as healthcare cost trends, regulatory changes, competitive pressures, and integration risks from acquisitions. The company emphasizes its commitment to transparency and compliance with safe harbor provisions for forward-looking statements.

Key Highlights

1Anthem, Inc. (now Elevance Health) confirms its ability to meet previously stated earnings expectations.
2The confirmation is provided despite an adverse opinion issued by the Supreme Court of Ohio in a legal case (Dardinger v. Anthem Blue Cross and Blue Shield, et al.).
3Company officers will meet with securities analysts and investors during the weeks of December 23, 2002, December 30, 2002, and January 6, 2003.
4The filing references a November 4, 2002 press release and conference call which provided initial earnings expectations.
5The report includes a standard safe harbor statement for forward-looking information, cautioning investors about risks and uncertainties.
6Key risks mentioned include healthcare cost trends, premium rate increases, government regulation, competitor actions, and acquisition integration (e.g., Trigon Healthcare, Inc.).
7The company, through its CFO Michael L. Smith, is maintaining transparency regarding potential impacts on financial performance.

Elevance Health, Inc. 8-K Report (Dec 23, 2002)

Summary

Key Highlights

Frequently Asked Questions